About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Advanced Heart Care at Home | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03724695

Advanced Heart Care at Home

End-of-life (EOL) care for heart failure (HF) patients includes high healthcare utilization and costs, in part due to the lack of integration of optimal HF management and home-based palliative care. I...

Lead sponsor: University of Pennsylvania•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Pennsylvania

Collaborators

Penn Medicine Center for Health Care Innovation
Independence Blue Cross

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. At least 18 years of age
•2. Reside within Caring Way's geographic catchment
•3. Heart Failure ICD code from any previous healthcare encounter (inpatient or outpatient) in the 12 months prior to index hospitalization
•4. Admitted to a cardiology or hospitalist service
•5. Palliative Connect score greater than 0.3
•6. Index hospitalization during study period

Exclusion Criteria

•1. Less than 18 years of age
•2. Pregnant women
•3. Incarcerated patients
•4. Homeless patients
•5. Reside outside of Caring Way's geographic catchment
•6. Patients without an identifiable primary physician for AHCAH staff to communicate with as determined by the AHCAH liaison via EPIC
•7. Prior hospitalization during study period

Related studies

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure

NCT07550790 · Heart Failure Acute, Renal Dysfunction

RECRUITINGPhase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more

RECRUITINGPhase 2

Lysergic Acid Diethylamide (LSD) in Palliative Care

NCT05883540 · Palliative Care, Pain, and more

An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

NCT06148935 · Chronic Heart Failure With Reduced Ejection Fraction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 26, 2026Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment709

Start dateNov 2018

Last updatedJan 26, 2026

Condition

Palliative Care Heart Failure Health Care Utilization Quality Improvement

Locations shown

Perelman Center for Advanced Medicine

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions